NCT04618796

Brief Summary

1- Evaluate the impact of the COVID-19 pandemic on pediatric vaccinations compliance among children attending to Assiut University Children Hospital ,assess the general health profile of studied children.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 6, 2020

Completed
1.1 years until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

August 3, 2021

Status Verified

July 1, 2021

Enrollment Period

4 months

First QC Date

November 2, 2020

Last Update Submit

July 30, 2021

Conditions

Vaccine Refusal

Keywords

Covid19

Outcome Measures

Primary Outcomes (1)

  • Measure the vaccination coverage rate among the studied children after the COVID-19 pandemic

    The investigators evaluate factors effect on compliance as covid-19, scioeconomic status, poverty, chronic disease and residance.

    Baseline

Interventions

vaccineOTHER

Effect of COVID-19 pandemic on vaccination compliance among children attending Assiut University Children Hospital and what is the degree of that.

Eligibility Criteria

Age1 Year - 2 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children from 12 to 24 months

You may qualify if:

  • Children from 12 to 24 months who admitted in Assiut University Children Hospital or attending the outpatient clinics

You may not qualify if:

  • : Immunodeficiency (e.g chemotherapy, long term immunosuppressive therapy, hematologic tumor).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Vaccination RefusalCOVID-19

Interventions

Vaccines

Condition Hierarchy (Ancestors)

Treatment RefusalTreatment Adherence and ComplianceHealth BehaviorBehaviorPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Biological ProductsComplex Mixtures

Study Officials

  • Ismail lotfy, associated professor

    Assiut University

    STUDY DIRECTOR

  • Mohamed Hamdy, professor

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Gehad Gamal, resident doctor

CONTACT

01006011751gehadgamal098@gmail.com

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ressident doctor.

Study Record Dates

First Submitted

November 2, 2020

First Posted

November 6, 2020

Study Start

December 1, 2021

Primary Completion

April 1, 2022

Study Completion

May 1, 2022

Last Updated

August 3, 2021

Record last verified: 2021-07